Genialis™ Supermodel White Paper
A technical guide to the Genialis™ Supermodel The [...]
From motifs to medicines: Harnessing nature’s pharmacopeia for novel CNS therapies | TPM podcast #59
Genialis Launches BioBridge to Help Derisk Global Drug Development [...]
Genialis Launches BioBridge to Help Derisk Global Drug Development of China-origin Oncology Drugs
Supermodel-powered platform translates tumor biology across patient populations, addressing [...]
Fostering innovation at scale: it’s all about the ecosystem | TPM podcast #58
Genialis ASCO 2026 poster Genialis AACR [...]
To Infinity and beyond: the future of comprehensive testing and genetic medicine | TPM podcast #57
Genialis ASCO 2026 poster Genialis AACR [...]
Biology-informed predictive modeling and resistance monitoring in trastuzumab deruxtecan–treated metastatic breast cancer
We developed a biology-informed model that uses real-world multimodal [...]
The concierge CEO: Incubating the next generation of digital oncology companies | TPM podcast #56
Upcoming events AACR 2026 [...]
Genialis Supermodel Predicts Patient Response to HER2-Targeted Therapy Enhertu
At AACR 2026, the Genialis™ Supermodel–powered RNA survival model [...]
The Pulse of the Oncologist: Meeting clinicians and patients where they are to deliver precision medicine | TPM podcast #55
Upcoming events AACR 2026 [...]
An RNA-based survival model predicting real-world response to trastuzumab deruxtecan
Antibody-drug conjugates (ADCs) like trastuzumab deruxtecan (T-DXd, Enhertu) have [...]
